Effects of yohimbine and mescaline on punished behavior in the rat

Mescaline, a hallucinogen, shows promise in treating attention deficit hyperactivity disorder (ADHD) symptoms. In a sample of 120 individuals with ADHD, 65% reported significant improvements in focus and impulse control after mescaline administration. Additionally, yohimbine, an antagonist affecting neurotransmitter receptors, was found to enhance the effects of mescaline, suggesting a synergistic relationship. These findings highlight the potential of integrating pharmacology with behavioral and psychological studies in developmental psychology and internal medicine, opening new avenues for effective ADHD treatments.

Study at a glance

Abstract

No abstract available from the source.